Information Is Power and Freedom of Speech Is a Right

Article

Articles posted don't always bring the response we desire. Sometimes, they promote negative feedback.

Information is Power and Freedom of Speech is a Right

I was surprised by the number of negative comments my recent blog post about asparagus received. When the article was posted on CURE Magazine’s Facebook page, I never expected it to receive the type of response it did. As I read through the comments, I was confused.

In sharing the information included in the article, I intended to start a conversation and to share recent cancer-related news. As a breast cancer survivor, I take developments in the field of cancer research very seriously. That is why I am constantly perusing medical journals, news articles and medical libraries. I want to be abreast of the most recent information, and since cancer news isn’t always top on the priority list for media reporting, I do my own digging.

Comments like “click bait,” etc. negated the purpose of my article. And while I know not everyone will agree with everything published, it would be nice to know that people read with an open mind.

CURE has been kind enough to give cancer survivors the opportunity to voice their opinions, to share their own personal cancer journeys and to connect with others who’ve experienced similar health challenges. I am personally grateful for the opportunity to share. Cancer doesn’t always allow its victims the right to speak.

For the naysayers who viewed my post as a means to gain attention or publish fake news, shame on you. I check my sources and always include references when sharing medical information, unless it is something related to my own cancer experience.

To those disappointed by the article on asparagus, please know I wrote the article in a lighthearted fashion to present the information in a way that would give pause for thought. Each of us has to use information we read in the proper way. We glean the good and toss the bad, but in the process, we do need to consider the fact that not all news we read will be what we want to hear, and it certainly won’t always be pleasant.

Cancer is serious business, and I would never make light of it. For the past three and a half years, I have been in the most difficult trial of my life. Never a day goes by that I don’t think of the challenges cancer has presented me.

My post about asparagus did exactly what it was intended to do — it got people talking. It may not have been in the most positive of ways, but at least people were having conversations about the information.

Thank you to those who took time to actually read the article in its entirety. Hopefully, if you’ve read past posts, you’ve come to know me and a little of my character through my writing. For those who did not read the entire article, how can you form a conclusion when you haven’t taken time to read, think, and try to understand what the author was trying to convey?

I am not a medical professional and have never claimed to be. I am merely a woman whose world was turned upside down with cancer. I lost both breasts and many lymph nodes to cancer. I live daily with pain and the constant reminder of what cancer took from me.

Yes, the research regarding asparagus was done on rodents, but isn’t all medical research conducted on animals first? That’s the way scientists learn, by trial and error. Yes, asparagine is an amino acid produced in the human body and it does good things for us, and yes, L-asparaginase is a newly produced synthetic drug that is being tested for its beneficial uses in helping combat the effects of developing secondary tumors in the rodents fed large amounts of Asparagus.

Forgive me for venting, but I felt it my duty to rebut some of the negativity generated by this article.

We all want to understand and find ways to combat cancer. It seems we’ll never find a cure for this dreaded and most misunderstood disease but as long as we are able to read, write and process information, perhaps one day we will find a cure.

And just so you know, CURE Magazine nor any of its staff, encouraged me to write this article. I chose to do so of my own volition. Perhaps I should start including a disclaimer at the end of my posts — “The views, information, or opinions expressed in this article are those of the author, and do not necessarily represent those of CURE Magazine and its employees.”

Information does provide us with the power to make our own choices and the freedom to share information via free speech is my right not only as an American citizen, but also as a freelance writer. It’s your choice whether or not you read my posts. I hope you’ll choose to continue to read a variety of opinions as they are expressed by all of the voices shared in CURE. Each of us has a unique story and all of us have something important to say.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content